Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF

被引:33
作者
Funaoka, K
Shindoh, M
Yoshida, K
Hanzawa, M
Hida, K
Nishikata, S
Totsuka, Y
Fujinaga, K
机构
[1] HOKKAIDO UNIV, SCH DENT, DEPT ORAL PATHOL, KITA KU, SAPPORO, HOKKAIDO 060, JAPAN
[2] HOKKAIDO UNIV, SCH DENT, DEPT ORAL SURG 2, SAPPORO, HOKKAIDO 060, JAPAN
[3] SAPPORO MED UNIV, SCH MED, CANC RES INST, DEPT BIOL MOL, SAPPORO, HOKKAIDO 060, JAPAN
关键词
D O I
10.1006/bbrc.1997.6909
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p21(Waf1/Cip1) is one of the key regulatory proteins in cell cycle, terminal differentiation, and apoptosis. Its promoter was shown to be transactivated by the wild-type p53 protein as well as in a p53-independent manner. In this report, we demonstrate that E1AF, an ets-related transcription factor, activated the human p21(Waf1/Cip1) promoter by interacting with the ets-binding sites located close to the two previously identified p53-responsive elements. Northern blot analysis revealed that p21(Waf1/Cip1) and E1AF were correlatively upregulated in response to cisplatin treatment in SiHa cells. Transient expression assays demonstrated that E1AF can activate the p21(Waf1/Cip1) promoter-driven luciferase reporter gene in SiHa cells. The p21(Waf1/Cip1) promoter activity was also increased in p53-null Saos2 osteosarcoma cells, but was markedly reduced when the ets-binding sites were deleted. These results indicate that E1AF positively regulates transcription from the p21(Waf1/Cip1) promoter in response to genotoxic stresses. (C) 1997 Academic Press.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 33 条
  • [1] BAE L, 1995, CANCER RES, V55, P2387
  • [2] BUTZ K, 1995, ONCOGENE, V10, P927
  • [3] SEPARATE DOMAINS OF P21 INVOLVED IN THE INHIBITION OF CDK KINASE AND PCNA
    CHEN, JJ
    JACKSON, PK
    KIRSCHNER, MW
    DUTTA, A
    [J]. NATURE, 1995, 374 (6520) : 386 - 388
  • [4] P53-DEPENDENT INHIBITION OF CYCLIN-DEPENDENT KINASE-ACTIVITIES IN HUMAN FIBROBLASTS DURING RADIATION-INDUCED G1 ARREST
    DULIC, V
    KAUFMANN, WK
    WILSON, SJ
    TLSTY, TD
    LEES, E
    HARPER, JW
    ELLEDGE, SJ
    REED, SI
    [J]. CELL, 1994, 76 (06) : 1013 - 1023
  • [5] ELDEIRY WS, 1994, CANCER RES, V54, P1169
  • [6] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [7] ELDEIRY WS, 1995, CANCER RES, V55, P2910
  • [8] FRITSCHE M, 1993, ONCOGENE, V8, P307
  • [9] Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with Adriamycin by using a p53-independent pathway
    Gartenhaus, RB
    Wang, P
    Hoffmann, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) : 265 - 268
  • [10] INHIBITION OF CYCLIN-DEPENDENT KINASES BY P21
    HARPER, JW
    ELLEDGE, SJ
    KEYOMARSI, K
    DYNLACHT, B
    TSAI, LH
    ZHANG, PM
    DOBROWOLSKI, S
    BAI, C
    CONNELLCROWLEY, L
    SWINDELL, E
    FOX, MP
    WEI, N
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1995, 6 (04) : 387 - 400